| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |